Why the study?
There is a complex interplay between isoforms and binding partners to regulate myosin VI, which is achieved through alternative isoform splicing and interactions with a network of binding partners.
This study elucidates a generic mechanism by which binding partners relieve myosin VI autoinhibition to activate its motor function.
Advances basic myosin regulation in animal models; leaves open human translation and clinical relevance.
Myosin VI is the only minus-end actin motor and is coupled to various cellular processes ranging from endocytosis to transcription. This multi-potent nature is achieved through alternative isoform splicing and interactions with a network of binding partners. There is a complex interplay between isoforms and binding partners to regulate myosin VI. Here, we have compared the regulation of two myosin VI splice isoforms by two different binding partners. By combining biochemical and single-molecule approaches, we propose that myosin VI regulation follows a generic mechanism, independently of the spliced isoform and the binding partner involved. We describe how myosin VI adopts an autoinhibited backfolded state which is released by binding partners. This unfolding activates the motor, enhances actin binding and can subsequently trigger dimerization. We have further expanded our study by using single molecule imaging to investigate the impact of binding partners upon myosin VI molecular organisation and dynamics.
No takes yet. Share an insight, caveat, or question.
Santos et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: